Does COVID-19 pandemic disrupt sustainable supply chain process? Covering some new global facts. 2021

Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
School of Public Administration, Xi'an University of Architecture and Technology, Xi'an, 710000, China.

The adverse effects of the coronavirus 2019 (COVID-19) pandemic are widely visible in the economic structure, while the principal causal factor is the disruption of the supply chain process that leads to the economies into a global depression. The purpose of the study is to identify the critical factors that affect the global sustainable supply chain process in the cross-sectional panel of 38 European countries, 14 North American countries, 40 Asian countries, and a heterogeneous panel of 111 countries. The results show that an increase in susceptible coronavirus cases and death tolls limits the supply chain process because of nationwide closures of industries and business activities. In contrast, an increase in the number of recovered cases supports economic activities and improved logistic performance index across countries. The innovation accounting matrix shows that since August 2020, the global coronavirus cases will decline and start resuming economic activities to increase the supply chain process. The result is further supported by the estimates of reduction in the proportion of death to recovered cases (case fatality ratio 1) to increase sustainable logistics activities. However, the supply chain process could affect an increasing death toll and case fatality ratio 2 (i.e., the proportion of death to registered cases) over time. The global economies should ensure a free flow of sustainable logistics supply, especially the supply of healthcare medical equipment that would help control the coronavirus pandemic, which escapes from the nations from a global depression.

UI MeSH Term Description Entries
D003132 Commerce The interchange of goods or commodities, especially on a large scale, between different countries or between populations within the same country. It includes trade (the buying, selling, or exchanging of commodities, whether wholesale or retail) and business (the purchase and sale of goods to make a profit). (From Random House Unabridged Dictionary, 2d ed, p411, p2005 & p283) Business,Commercial Sector,Prices,Sales,Vendors,Businesses,Commerces,Commercial Sectors,Price,Sale,Sector, Commercial,Sectors, Commercial,Vendor
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003695 Delivery of Health Care The concept concerned with all aspects of providing and distributing health services to a patient population. Delivery of Dental Care,Health Care,Health Care Delivery,Health Care Systems,Community-Based Distribution,Contraceptive Distribution,Delivery of Healthcare,Dental Care Delivery,Distribution, Non-Clinical,Distribution, Nonclinical,Distributional Activities,Healthcare,Healthcare Delivery,Healthcare Systems,Non-Clinical Distribution,Nonclinical Distribution,Activities, Distributional,Activity, Distributional,Care, Health,Community Based Distribution,Community-Based Distributions,Contraceptive Distributions,Deliveries, Healthcare,Delivery, Dental Care,Delivery, Health Care,Delivery, Healthcare,Distribution, Community-Based,Distribution, Contraceptive,Distribution, Non Clinical,Distributional Activity,Distributions, Community-Based,Distributions, Contraceptive,Distributions, Non-Clinical,Distributions, Nonclinical,Health Care System,Healthcare Deliveries,Healthcare System,Non Clinical Distribution,Non-Clinical Distributions,Nonclinical Distributions,System, Health Care,System, Healthcare,Systems, Health Care,Systems, Healthcare
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
April 2023, Engineering applications of artificial intelligence,
Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
March 2022, iScience,
Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
July 2022, The World economy,
Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
February 2022, Technology in society,
Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
March 2023, Environmental science and pollution research international,
Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
September 2021, Environmental science and pollution research international,
Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
April 2021, Engineering applications of artificial intelligence,
Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
June 2020, Nature human behaviour,
Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
April 2021, Transportation research. Part E, Logistics and transportation review,
Muhammad Khalid Anser, and Muhammad Azhar Khan, and Abdelmohsen A Nassani, and Muhammad Moinuddin Qazi Abro, and Khalid Zaman, and Ahmad Kabbani
January 2021, Journal of clinical nursing,
Copied contents to your clipboard!